194 related articles for article (PubMed ID: 2096158)
1. Gangliosides and phospholipids in human thyroids responsive and unresponsive to thyrotropin.
Mariano A; Di Carlo A; Macchia PE; Pisano G; Parmeggiani U; Macchia V
J Endocrinol Invest; 1990 Nov; 13(10):817-23. PubMed ID: 2096158
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor and thyrotropin response in human thyroid tissues.
Di Carlo A; Mariano A; Pisano G; Parmeggiani U; Beguinot L; Macchia V
J Endocrinol Invest; 1990 Apr; 13(4):293-9. PubMed ID: 2164546
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B.
Mirkin BL; Clark SH; Zhang C
Cell Prolif; 2002 Apr; 35(2):105-15. PubMed ID: 11952645
[TBL] [Abstract][Full Text] [Related]
4. Gangliosides of liver tumors induced by N-2-fluorenylacetamide. I. Ganglioside alterations in liver tumorigenesis and normal development.
Merritt WD; Richardson CL; Keenan TW; Morré DJ
J Natl Cancer Inst; 1978 Jun; 60(6):1313-27. PubMed ID: 206706
[TBL] [Abstract][Full Text] [Related]
5. Specific ganglioside changes in extraneural tissues of adult rats with hypothyroidism.
Saito M; Sugiyama K
Biochim Biophys Acta; 2000 Oct; 1523(2-3):230-5. PubMed ID: 11042389
[TBL] [Abstract][Full Text] [Related]
6. Effect of thyroid-stimulating hormone and norepinephrine on cyclic AMP levels in human normal thyroids and human thyroid tumors.
Aiyoshi Y; Yamashita K; Fujimoto Y
Endocrinol Jpn; 1980 Oct; 27(5):625-30. PubMed ID: 6263597
[TBL] [Abstract][Full Text] [Related]
7. Stimulatory effect of vasoactive intestinal polypeptide on human normal and neoplastic thyroid tissue.
Siperstein AE; Miller RA; Clark OH
Surgery; 1988 Dec; 104(6):985-91. PubMed ID: 2848326
[TBL] [Abstract][Full Text] [Related]
8. Developmental changes in ganglioside composition and synthesis in embryonic rat brain.
Yu RK; Macala LJ; Taki T; Weinfield HM; Yu FS
J Neurochem; 1988 Jun; 50(6):1825-9. PubMed ID: 3131485
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides.
Miljan EA; Meuillet EJ; Mania-Farnell B; George D; Yamamoto H; Simon HG; Bremer EG
J Biol Chem; 2002 Mar; 277(12):10108-13. PubMed ID: 11796728
[TBL] [Abstract][Full Text] [Related]
10. Ganglioside composition in human meningiomas.
Davidsson P; Fredman P; Collins VP; von Holst H; Mänsson JE; Svennerholm L
J Neurochem; 1989 Sep; 53(3):705-9. PubMed ID: 2760617
[TBL] [Abstract][Full Text] [Related]
11. Effects of thyroid-stimulating hormone on human thyroid carcinoma and adjacent normal tissue.
Field JB; Bloom G; Chou MC; Kerins ME; Larsen PR; Kotani M; Kariya T; Dekker A
J Clin Endocrinol Metab; 1978 Nov; 47(5):1052-8. PubMed ID: 233688
[TBL] [Abstract][Full Text] [Related]
12. Ganglioside shedding and changes in ceramide biosynthesis in human ovarian tumors.
Dyatlovitskaya EV; Andreasyan GO; Malykh YaN ; Rylova SN; Somova OG
Biochemistry (Mosc); 1997 May; 62(5):557-61. PubMed ID: 9275295
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
Schnaar RL; Fromholt SE; Gong Y; Vyas AA; Laroy W; Wayman DM; Heffer-Lauc M; Ito H; Ishida H; Kiso M; Griffin JW; Shiekh KA
Anal Biochem; 2002 Mar; 302(2):276-84. PubMed ID: 11878808
[TBL] [Abstract][Full Text] [Related]
14. Gangliosides of human thyroid gland.
Svennerholm L
Biochim Biophys Acta; 1985 Jul; 835(2):231-5. PubMed ID: 4005280
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin stimulation of 32P incorporation into the phospholipids of canine thyroid adenocarcinoma.
Schneider PB; Leav I
Endocrinology; 1977 Feb; 100(2):346-50. PubMed ID: 832628
[TBL] [Abstract][Full Text] [Related]
16. Gangliosides in rat kidney: composition, distribution, and developmental changes.
Saito M; Sugiyama K
Arch Biochem Biophys; 2001 Feb; 386(1):11-6. PubMed ID: 11360994
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin-ganglioside interactions and their relationship to the structure and function of thyrotropin receptors.
Mullin BR; Fishman PH; Lee G; Aloj SM; Ledley FD; Winand RJ; Kohn LD; Brady RO
Proc Natl Acad Sci U S A; 1976 Mar; 73(3):842-6. PubMed ID: 176657
[TBL] [Abstract][Full Text] [Related]
18. Major gangliosides in normal and pathological human thyroids.
Bouchon B; Portoukalian J; Bornet H
Biochem Int; 1985 Apr; 10(4):531-8. PubMed ID: 3839677
[TBL] [Abstract][Full Text] [Related]
19. Relationship of gangliosides to the structure and function of thyrotropin receptors: their absence on plasma membranes of a thyroid tumor defective in thyrotropin receptor activity.
Fishman PH; Aloj SM; Kohn LD; Brady RO
Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4060-4. PubMed ID: 186783
[TBL] [Abstract][Full Text] [Related]
20. Increased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease.
Miklavcic JJ; Hart TD; Lees GM; Shoemaker GK; Schnabl KL; Larsen BM; Bathe OF; Thomson AB; Mazurak VC; Clandinin MT
World J Gastroenterol; 2015 Sep; 21(35):10080-90. PubMed ID: 26401073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
